GSK plc Adjustments For Income Tax Expense
GSK plc (GLAXF) reported Adjustments For Income Tax Expense of GBP 1.11 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForIncomeTaxExpense · last filed 2026-03-06
| Period end | Adjustments For Income Tax Expense 12 month | Adjustments For Income Tax Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.11B GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 526.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 756.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 707.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 83.00M GBP 20-F · filed 2024-03-05 | 346.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 67.00M GBP 20-F · filed 2023-03-10 | 580.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 953.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 754.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 1.36B GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 877.00M GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 2.15B GBP 20-F/A · filed 2018-03-20 |